PBMs, like Optum Rx, are the key counterweight to pharmaceutical companies’ otherwise unchecked monopoly power to set and raise drug prices.

Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...

The Federal Trade Commission is suing the three largest prescription drug benefit managers (PBMs) for allegedly driving up ...

The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming ...

The complaint targets the group purchasing organizations affiliated with the "big three" pharmacy benefit managers: CVS ...

UnitedHealth Group's Optum Rx will join its peers in the big three pharmacy benefit managers by pulling Humira from some of ...

In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...

FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...

Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...